Powder: -20°C for 3 years | In solvent: -80°C for 1 year
M-5011 is a non-steroidal anti-inflammatory drug and immunomodulator potentially for the treatment of inflammation and pain. M-5011 had an effective antinociceptive activity (ED50 value) of 0.63 mg/kg. M-5011 partially inhibits the generalized bone loss accompanying the development of collagen-induced arthritis in rats. M-5011 is a useful NSAID that shows potent antinociceptive effects with low ulcerogenic activities.
产品描述 | M-5011 is a non-steroidal anti-inflammatory drug and immunomodulator potentially for the treatment of inflammation and pain. M-5011 had an effective antinociceptive activity (ED50 value) of 0.63 mg/kg. M-5011 partially inhibits the generalized bone loss accompanying the development of collagen-induced arthritis in rats. M-5011 is a useful NSAID that shows potent antinociceptive effects with low ulcerogenic activities. |
别名 | T-3788, S-MTPPA, M 5011, M-5011C |
分子量 | 246.32 |
分子式 | C14H14O2S |
CAS No. | 76604-64-3 |
Powder: -20°C for 3 years | In solvent: -80°C for 1 year
对于不同动物的给药剂量换算,您也可以参考 更多...
请在以下方框中输入您的动物实验信息后点击计算,可以得到母液配置方法和体内配方的制备方法: 比如您的给药剂量是10 mg/kg,每只动物体重20 g,给药体积100 μL,一共给药动物10 只,您使用的配方为5% DMSO+30% PEG300+5% Tween 80+60% ddH2O。那么您的工作液浓度为2 mg/mL。
母液配置方法:2 mg 药物溶于 50 μL DMSO (母液浓度为 40 mg/mL), 如您需要配置的浓度超过该产品的溶解度,请先与我们联系。
体内配方的制备方法:取 50 μL DMSO 主液,加入 300 μL PEG300, 混匀澄清,再加 50 μL Tween 80,混匀澄清,再加 600 μL ddH2O, 混匀澄清。
您可能有的问题的答案可以在抑制剂处理说明中找到,包括如何准备库存溶液,如何存储产品,以及基于细胞的分析和动物实验需要特别注意的问题。
M-5011 76604-64-3 T-3788 S-MTPPA M 5011 M-5011C T3788 M5011 T 3788 Inhibitor inhibitor inhibit